In patients with treatment-resistant depression who responded to intranasal esketamine plus an antid...

Repeat infusions of ketamine, starting thrice weekly then transitioning to once weekly, elicit a cum...

An independent advisory panel to the Food and Drug Administration (FDA) on Tuesday endorsed the eske...

The Food and Drug Administration (FDA) issued a final order on Wednesday to downgrade the risk categ...

Repetitive transcranial magnetic stimulation (rTMS) helped more than 40% of veterans with treatment-...

It is well known that some patients with depression will fail to respond to medications, but clinici...

Clinicians may want to consider electroconvulsive therapy (ECT) for patients with major depressive d...

Despite its effectiveness in treating severe depression, the use of electroconvulsive therapy (ECT) ...

Intranasal esketamine taken twice weekly can rapidly reduce symptoms of people with treatment-resist...